Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 6748-6755

  Trembleau, S ^a   Penna, G ^a   Gregori, S ^a   Magistrelli, G ^a   Isacchi, A ^a   Adorini, L ^a  

^a ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN RECEPTOR; TYROSINE PHOSPHATASE LIKE INSULINOMA ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0034671983     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.6748     Document Type: Article

References (78)

1. Type-I diabetes a chronic autoimmune disease of human, mouse, and rat
2. The NOD mouse model of type 1 diabetes as good as it gets?
3. Insulin-dependent diabetes mellitus as an autoimmune disease
4. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
5. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease
6. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells
7. + Th1 cells reduce diabetes in NOD/SCID mice
8. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
9. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice
10. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
11. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library
12. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
13. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2
14. Identification of protein tyrosin phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes related 37/40K autoantigen and a target of islet-cell antibodies
15. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512)
16. Autoantibodies to IA-2 and IA-2β in insulin-dependent diabetes mellitus recognize conformational epitopes location of the 37- and 40-kDa fragments determined
17. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes the 2-year analysis of the German BABYDIAB Study
18. Antibodies to islet 37K antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity
19. Antibodies to ICA512/IA-2 in rodent models of IDDM
20. Autoantibodies to IA-2 not detected in NOD mice or BB rats
21. Immunization therapies in the prevention of diabetes
22. A peptide-binding motif for I-A(g7), the class II MHC molecule of NOD and Biozzi AB/H mice
23. Expression of PTP35, the murine homologue of the protein tyrosine phosphatase-rela ed sequence IA-2, is regulated during cell growth and stimulated by mitogens in 3T3 fibroblasts
24. Substitution of two variant residues in the protein tyrosine phosphatase-like PTP35/IA-2 sequence reconstitutes catalytic activity
25. + gene occurs in humans and is highly expressed in some cancer cells
26. IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice
27. Epitope specific binding of CD8 regulates activation of T cells and induction of cytotoxicity
28. Monoclonal antibodies against murine γ interferon
29. Two types of mouse helper T cell clone III Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally mono-specific bioassays, and monoclonal antibodies
30. Complete characterization of the expressed immune response genes in Biozzi AB/H mice structural and functional identity between AB/H and NOD A region molecules
31. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes
32. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)
33. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease
34. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes
35. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases
36. Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus precursor of the 37-kDa tryptic fragment
37. Molecular cloning of phogrin, a proteintyrosine phosphatase homologue localized to insulin secretory granule membranes
38. Cloning and characterization of islet cell antigen-related protein-tyrosine phosphatase (PTP), a novel receptor-like PTP and autoantigen in insulin-dependent diabetes
39. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2
40. Islet cell antigens in insulin-dependent diabetes Pandora's box revisited
41. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes Combinatorial Islet Autoantibody Workshop
42. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with 1DDM The DENIS Study Group Deutsche Nikotinamid Interventions-Studie
43. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice
44. GAD65 is recognized by T-cells, but not by antibodies from NOD-mice
45. Absence of autoantibodies against glutamate decarboxylase (GAD) in the non-obese diabetic (NOD) mouse and low expression of the enzyme in mouse islets
46. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus
47. Early expression of antiinsulin autoantibodies of humans and the NOD mouse evidence for early determination of subsequent diabetes
48. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation
49. Cellular immunity to human insulin in individuals at high risk for the development of type 1 diabetes mellitus
50. Response of peripheralblood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes
51. Glutamic acid decarboxylase 67-reactive T cells a marker of insulin-dependent diabetes
52. Cellular immune response to diverse islet cell antigens in IDDM
53. Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus report of the first international workshop for standardization of T cell assays
54. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients
55. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2 potential for mimicry with rotavirus and other environmental agents
56. T-cell lines to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes
57. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(α1*0101, β1*0401) transgenic mice
58. Determination of glutamic acid decarboxylase 65 peptides presented by the type 1 diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif
59. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin
60. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4
61. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice
62. Lymph node T-cells do not optimally transfer diabetes in NOD mice
63. Defective activation of T suppressor cell function in nonobese diabetic mice potential relation to cytokine deficiencies
64. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
65. Mapping of the IDDM locus Idd3 to a 0 35-cM interval containing the interleukin-2 gene
66. Analysis of the spontaneous T cell response to insulin in NOD mice
67. Cellular immune response to phogrin in the NOD mouse cloned T-cells cause destruction of islet transplants
68. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
69. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice
70. Evidence for interleukin-6 production by and effects on pancreatic β cells
71. Demonstration of a Th1 cytokine profile in the late phase of NOD insulitis
72. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice
73. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice
74. Gp130 and the interleukin-6 family of cytokines
75. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
76. Induction of autoimmune diabetes by oral administration of autoantigen
77. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens
78. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration